Ian Clements
Net Worth
Last updated:
What is Ian Clements net worth?
The estimated net worth of Dr. Ian Clements is at least $4,486,644 as of 26 Nov 2021. He owns shares worth $1,209,435 as insider, has earned $30,309 from insider trading and has received compensation worth at least $3,246,900 in Mirum Pharmaceuticals, Inc..
What is the salary of Ian Clements?
Dr. Ian Clements salary is $541,150 per year as Chief Financial Officer in Mirum Pharmaceuticals, Inc..
How old is Ian Clements?
Dr. Ian Clements is 56 years old, born in 1969.
What stocks does Ian Clements currently own?
As insider, Dr. Ian Clements owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | Chief Financial Officer | 18,561 | $65.16 | $1,209,435 |
What does Mirum Pharmaceuticals, Inc. do?
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Mirum Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Foster City, California.
Ian Clements insider trading
Mirum Pharmaceuticals, Inc.
Dr. Ian Clements has made only one insider trade between 2019-2021, according to the Form 4 filled with the SEC. He purchased 750 units of MIRM stock worth $10,425 on 26 Nov 2021.
As of 26 Nov 2021 he still owns at least 18,561 units of MIRM stock.
Mirum Pharmaceuticals key executives
Mirum Pharmaceuticals, Inc. executives and other stock owners filed with the SEC:
- Dr. Ian Clements (56) Chief Financial Officer
- Mr. Christopher Peetz (46) Pres, Chief Executive Officer & Director
- Mr. Peter Radovich M.B.A., Ph.D. (47) Chief Operating Officer